GEODE CAPITAL MANAGEMENT, LLC - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 24 filers reported holding CANDEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$129,529
-21.6%
139,253
+6.1%
0.00%
Q2 2023$165,315
-8.0%
131,2030.0%0.00%
Q1 2023$179,748
+76715.4%
131,2030.0%0.00%
Q4 2022$234
-99.9%
131,203
+1.8%
0.00%
Q3 2022$404,000
+66.3%
128,846
+71.3%
0.00%
Q2 2022$243,000
-36.4%
75,2170.0%0.00%
Q1 2022$382,000
-16.0%
75,217
+29.1%
0.00%
Q4 2021$455,000
+105.9%
58,285
+185.8%
0.00%
Q3 2021$221,00020,3950.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$1,780,3985.13%
Sands Capital Ventures, LLC 811,737$746,7980.22%
Empirical Asset Management, LLC 10,000$9,2000.01%
Baystate Wealth Management LLC 97,310$89,5250.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,595$123,3130.00%
FRANKLIN RESOURCES INC 1,125,000$1,046,2500.00%
OneDigital Investment Advisors LLC 25,428$23,3940.00%
WELLS FARGO & COMPANY/MN 108$990.00%
NORTHERN TRUST CORP 19,617$18,0480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders